Massive study reveals hidden dangers of common steroid treatments
NCT ID NCT06488703
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at over 107,000 patients in Germany to understand the long-term side effects of systemic steroids (corticosteroids) used for conditions like asthma, COPD, and arthritis. Researchers compared patients who took steroids with those who did not, tracking risks such as diabetes, heart disease, osteoporosis, and infections. The goal was to measure how often these side effects occur and their economic impact on the healthcare system.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
systemic glucocorticoids (steroids)
What this could lead to
If successful, this research could help doctors better weigh the risks of long-term steroid use and find ways to reduce harmful side effects.
What could go wrong
This is a retrospective analysis of existing data, not a controlled trial. It can show links but cannot prove cause and effect. Results may not apply to all patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rwth Aachen University-Aachen-Germany-C
Germany, Germany